Table 1

Participants’ characteristics at baseline

Total (N=45)
Female sex41 (91.1%)
Age (years)57 (49–66)
Eye symptoms39 (86.7%)
Oral symptoms41 (91.1%)
ESSPRI6.0 (4.2–6.7)
Use of artificial tears36 (80.0%)
Systemic involvement (ESSDAI>0)28 (62.2%)
ESSDAI score2.0 (1.0–4.0)
Schirmer’s test <5 mm/5 min35 (77.8%)
Abnormal ocular surface staining test27 (61.4%)
Unstimulated whole salivary flow <1.5 mL/15 min33 (75.0%)
Focal sialadenitis (focus score ≥1)40 (88.9%)
Presence of anti-SSA antibodies36 (80.0%)
Presence of anti-SSB antibodies17 (37.8%)
  • Results are reported as N (%), or median (IQR).

  • ESSDAI, Eular Sjögren Syndrome Disease Activity Index; ESSPRI, EULAR Sjrogen's Syndrome Patient Reported Index.